CID 16131950

Hiv-1 12-mer tar rna containing 2'-o-methyl and 2',4'-locked nucleotides: 5'-[2'-ome(c)--lna(t)-2'-ome(c)-lna(c)-2'-ome(c)-lna(a)-2'-ome(g)-lna(g)-2'-ome(c)-lna(t)-2'-ome(c)-2'-ome(a)-l-homoserine-6-carboxyfluorescein]

Structural Information

Molecular Formula
C151H180N44O92P12
SMILES
CC1=CN(C(=O)NC1=O)C2C3C(C(O2)(CO3)COP(=O)(O)OC4C(OC(C4O)N5C=CC(=NC5=O)N)CO)OP(=O)(O)OCC6C(C(C(O6)N7C=CC(=NC7=O)N)OC)OP(=O)(O)OCC89COC(C8OP(=O)(O)OCC1C(C(C(O1)N1C=CC(=NC1=O)N)OC)OP(=O)(O)OCC12COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C1N=C(NC3=O)N)OC)OP(=O)(O)OCC13COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=CC(=NC1=O)N)OC)OP(=O)(O)OCC14COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=CC(=NC1=O)N)OC)OP(=O)(O)OCC1C(C(C(O1)N1C=NC5=C(N=CN=C51)N)OC)OP(=O)(O)OCC[C@@H](C(=O)N)NC(=O)C1=CC5=C(C=C1)C(=O)OC51C5=C(C=C(C=C5)O)OC5=C1C=CC(=C5)O)C(O4)N1C=C(C(=O)NC1=O)C)C(O3)N1C=NC3=C1N=C(NC3=O)N)C(O2)N1C=NC2=C(N=CN=C21)N)C(O9)N1C=C(C(=NC1=O)N)C
InChI
InChI=1S/C151H180N44O92P12/c1-57-31-189(143(212)177-110(57)157)130-100-105(147(270-130,42-245-100)47-258-296(231,232)279-89-72(265-125(95(89)240-5)186-24-18-79(154)174-140(186)209)38-254-292(223,224)284-106-101-131(190-32-58(2)118(201)182-144(190)213)271-146(106,41-246-101)46-257-295(229,230)276-87-70(34-196)263-123(86(87)199)184-22-16-77(152)172-138(184)207)283-291(221,222)253-37-73-91(97(242-7)127(266-73)188-26-20-81(156)176-142(188)211)281-298(235,236)260-49-149-44-248-103(133(273-149)193-54-168-83-112(159)164-52-166-115(83)193)108(149)286-294(227,228)256-40-76-93(99(244-9)129(269-76)194-55-169-84-116(194)178-136(161)180-121(84)204)282-299(237,238)261-50-150-45-249-104(134(274-150)195-56-170-85-117(195)179-137(162)181-122(85)205)109(150)287-293(225,226)255-39-74-90(96(241-6)126(267-74)187-25-19-80(155)175-141(187)210)280-297(233,234)259-48-148-43-247-102(132(272-148)191-33-59(3)119(202)183-145(191)214)107(148)285-290(219,220)252-36-71-88(94(239-4)124(264-71)185-23-17-78(153)173-139(185)208)278-289(217,218)251-35-75-92(98(243-8)128(268-75)192-53-167-82-111(158)163-51-165-114(82)192)277-288(215,216)250-27-21-67(113(160)200)171-120(203)60-10-13-63-66(28-60)151(275-135(63)206)64-14-11-61(197)29-68(64)262-69-30-62(198)12-15-65(69)151/h10-20,22-26,28-33,51-56,67,70-76,86-109,123-134,196-199H,21,27,34-50H2,1-9H3,(H2,160,200)(H,171,203)(H,215,216)(H,217,218)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H2,152,172,207)(H2,153,173,208)(H2,154,174,209)(H2,155,175,210)(H2,156,176,211)(H2,157,177,212)(H2,158,163,165)(H2,159,164,166)(H,182,201,213)(H,183,202,214)(H3,161,178,180,204)(H3,162,179,181,205)/t67-,70?,71?,72?,73?,74?,75?,76?,86?,87?,88?,89?,90?,91?,92?,93?,94?,95?,96?,97?,98?,99?,100?,101?,102?,103?,104?,105?,106?,107?,108?,109?,123?,124?,125?,126?,127?,128?,129?,130?,131?,132?,133?,134?,146?,147?,148?,149?,150?/m0/s1
InChIKey
LKTIOLUJRPZLAW-OREJCOOESA-N
Compound name
[7-[[3-[[7-[[3-[[7-[[3-[[7-[[3-[[7-[[3-[[3-[[(3S)-4-amino-3-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]-4-oxobutoxy]-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(2-amino-6-oxo-1H-purin-9-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(6-aminopurin-9-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methyl [5-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

4452.761 Da
Monoisotopic Mass

-31.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 4453.7683 312.4
[M+Na]+ 4475.7502 312.7
[M-H]- 4451.7537 312.5
[M+NH4]+ 4470.7948 312.5
[M+K]+ 4491.7242 312.4
[M+H-H2O]+ 4435.7583 312.2
[M+HCOO]- 4497.7592 312.4
[M+CH3COO]- 4511.7749 312.4
[M+Na-2H]- 4473.7357 312.7
[M]+ 4452.7605 312.6
[M]- 4452.7615 312.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.